Skip to content

Efficacy of Black Seed Oil in Patients With Type 2 Diabetes Mellitus

Effect of Black Seed Oil on Markers of Endothelial Dysfunction in Patients With Type 2 Diabetes Mellitus

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03959306
Enrollment
50
Registered
2019-05-22
Start date
2019-04-24
Completion date
2019-08-31
Last updated
2019-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

Type 2 Diabetes Mellitus, Black Seed Oil, Endothelial Dysfunction

Brief summary

The purpose of this study is to determine the effect of black seed oil on markers of endothelial dysfunction in patients with type 2 diabetes mellitus .Also, to investigate its effect on glycemic control ,lipid profile and quality of life of those patients .

Interventions

DIETARY_SUPPLEMENTBlack Seed Oil

Black seed oil soft gelatin capsule

standard anti-diabetic treatment prescribed for the patient

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age: adult patients with more than or equal 18 years old. 2. Previous diagnosis of Diabetes mellitus type 2 according to American Diabetes Association Criteria (ADA). 3. Approval to participate and give informed consent.

Exclusion criteria

1. Unstable coronary artery disease, cardiac arrhythmia or congestive heart failure. 2. Uncontrolled hypertension or recent stroke. 3. Chronic kidney disease or chronic liver disease. 4. Intake of black seed oil during the previous two months or any other antioxidant.

Design outcomes

Primary

MeasureTime frameDescription
Effect on Markers of Endothelial Dysfunction(The change in the level of soluble intercellular adhesion molecule ( ICAM) in serum using ELISA kit)three monthsit will be assessed at baseline and after three months of treatment ( to determine the change from baseline at three months ) to determine whether it is effective in reducing marker of endothelial dysfunction (ICAM) in patients with type 2 diabetes mellitus

Secondary

MeasureTime frameDescription
Effect on Glycemic Control (Measurement of fasting blood glucose )three monthsit will be assessed at baseline and after three months of treatment to determine the anti-diabetic effect of black seed oil ( if it is effective in reducing fasting blood glucose from baseline)
Effect on Glycemic Control (Measurement of glycated hemoglobin)three monthsit will be assessed at baseline and after three months of treatment to determine the anti-diabetic effect of black seed oil ( if it is effective in reducing glycated hemoglobin from baseline)
Effect on Lipid Profile ( Measurement of TC,TG, HDL-C,LDL-C)three monthsit will be assessed at baseline and after three months of treatment
Effect on Inflammatory Status ( Measurement of High sensitive C-Reactive Protein using ELISA kit)three monthsit will be assessed at baseline and after three months of treatment
Effect on Quality of Life ( Using Diabetes-39 questionnaire )three monthsit will be assessed at baseline and after three months of treatment

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026